TP53 and familial dilated cardiomyopathy: Consistent with the results of the in vitro experiments, treatment with RWPH and RWPE significantly alleviated the increase in Bax/Bcl-2 ratio, Bax and p53 as well as the decrease in Bcl-2 in DCM mice (Figures 4E–H).